Honeywell 2007 Annual Report Download - page 76

HONEYWELL INTERNATIONAL INC.
NOTES TO FINANCIAL STATEMENTS—(Continued)
(Dollars in millions, except per share amounts)
Other Intangible Assets with Determinable Lives—Other intangible assets with determinable lives consist
of customer lists, technology, patents and trademarks and other intangibles and are amortized over their
estimated useful lives, ranging from 2 to 24 years.
Long-Lived Assets—We periodically evaluate the recoverability of the carrying amount of long-lived assets
(including property, plant and equipment and intangible assets with determinable lives) whenever events or
changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable. We
evaluate events or changes in circumstances based on a number of factors including operating results, business
plans and forecasts, general and industry trends and, economic projections and anticipated cash flows. An
impairment is assessed when the undiscounted expected future cash flows derived from an asset are less than
its carrying amount. Impairment losses are measured as the amount by which the carrying value of an asset
exceeds its fair value and are recognized in earnings. We also continually evaluate the estimated useful lives of
all long-lived assets and periodically revise such estimates based on current events.
Sales Recognition—Product and service sales are recognized when persuasive evidence of an
arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or
determinable, and collection is reasonably assured. Service sales, principally representing repair, maintenance
and engineering activities in our Aerospace and Automation and Control Solutions segments, are recognized
over the contractual period or as services are rendered. Sales under long-term contracts in the Aerospace and
Automation and Control Solutions segments are recorded on a percentage-of-completion method measured on
the cost-to-cost basis for engineering-type contracts and the units-of-delivery basis for production-type contracts.
Provisions for anticipated losses on long- term contracts are recorded in full when such losses become evident.
Revenues from contracts with multiple element arrangements are recognized as each element is earned based
on the relative fair value of each element provided the delivered elements have value to customers on a
standalone basis. Amounts allocated to each element are based on its objectively determined fair value, such as
the sales price for the product or service when it is sold separately or competitor prices for similar products or
services.
Environmental Expenditures—Environmental expenditures that relate to current operations are expensed
or capitalized as appropriate. Expenditures that relate to an existing condition caused by past operations, and
that do not provide future benefits, are expensed as incurred. Liabilities are recorded when environmental
remedial efforts or damage claim payments are probable and the costs can be reasonably estimated. Such
liabilities are based on our best estimate of the undiscounted future costs required to complete the remedial
work. The recorded liabilities are adjusted periodically as remediation efforts progress or as additional technical,
regulatory or legal information becomes available. Given the uncertainties regarding the status of laws,
regulations, enforcement policies, the impact of other potentially responsible parties, technology and information
related to individual sites, we do not believe it is possible to develop an estimate of the range of reasonably
possible environmental loss in excess of our recorded liabilities.
Asbestos Related Contingencies and Insurance Recoveries—Honeywell is a defendant in personal injury
actions related to products containing asbestos (refractory and friction products). We recognize a liability for any
asbestos related contingency that is probable of occurrence and reasonably estimable. Regarding North
American Refractories Company (NARCO) asbestos related claims, we accrue for pending claims based on
terms and conditions, including evidentiary requirements, in definitive agreements or agreements in principle with
current claimants. We also accrued for the probable value of future NARCO asbestos related claims through
2018 based on the disease criteria and payment values contained in the NARCO trust as described in Note 21.
In light of the inherent uncertainties in making long term projections regarding claims filing rates and disease
manifestation, we do not believe that we have a reasonable basis for estimating NARCO asbestos claims beyond
2018 under Statement of Financial Accounting Standards No. 5, "Accounting for Contingencies" (SFAS
52